Evidence map›Paper›PMID 35871733›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2022

[Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m

Rui Gu, Min Liu, Ping Lin, Tian-Yu Feng, Hang Yuan, De-Qiong Ou, Si-Qi Li, Qin Li, Gang Zhao, Jie Zhang and 1 more

Open access · greenAbstract read
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. A comprehensive review of mEpigenomics · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Rui GuLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Min LiuLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Ping LinLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Tian-Yu FengLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Hang YuanLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
De-Qiong OuLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Si-Qi LiLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Qin LiLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Gang ZhaoLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Jie ZhangLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Kai LiLab of Experimental Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To study the correlation between N Methods: We identified m Results: A total of 343 m Conclusion: The prognostic risk model constructed on the basis of the aforementioned 7 m

Indexed as

RNA, Long NoncodingUterine Cervical NeoplasmsBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticHumansImmunotherapyPrognosisBiomarkers, TumorRNA, Long NoncodingCervical cancerImmunotherapylncRNAm6A methylationPrognosis

Identifiers

PMID35871733
PMCPMC10409463
OpenAlexW4288045118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.